제1형 당뇨병 환자에서의 집중적 인슐린 치료법
전체 글
수치
관련 문서
- Perform an annual test to assess urine albumin excretion in type 1 diabetic patients with diabetes duration of ≥ 5 years and in all type 2 diabetic patients starting at
• Phase II clinical trials of PI3Kδ inhibitor (idelalisib) showed dramatic response in patients with previously treated indolent non-hodgkin’s
1 John Owen, Justification by Faith Alone, in The Works of John Owen, ed. John Bolt, trans. Scott Clark, "Do This and Live: Christ's Active Obedience as the
Median overall survival of 28 multiple myeloma patients treated with Cyclophosphamide-Prednisone combination regimens as a primary therapy was 115 weeks.. Median
The Incomplete diffuse type PVD found primarily in patients with diabetic retinopathy and retinal detachment and complete diifuse type PVD found primarily in patients
(2002) Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in
It might also act in conjunction with a growth factor, such as bone morphogenic protein (BMP), insulin-like growth factor, or platelet-derived growth factor.
In this study, we found that Pin1 plays a pivotal role in insulin- induced AP-1 activation through its interaction with p70S6K and prolongs activity of
